{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:24:02Z","timestamp":1768688642172,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bbmt.2015.12.025","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T02:30:19Z","timestamp":1451529019000},"page":"771-775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients"],"prefix":"10.1016","volume":"22","author":[{"given":"Takahiro","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.12.025_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2009.03.003","article-title":"Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group","volume":"15","author":"Onozawa","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1700909","article-title":"Varicella vaccination in children after bone marrow transplantation","volume":"20","author":"Sauerbrei","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.12.025_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/bmt.2009.263","article-title":"Vaccination of hematopoietic cell transplant recipients","volume":"44","author":"Ljungman","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib6","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1704870","article-title":"Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT","volume":"35","author":"Ljungman","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.11150\/kansenshogakuzasshi.85.161","article-title":"Varicella vaccine potency and stability during transport and delivery","volume":"85","author":"Kamiya","year":"2011","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.bbmt.2015.12.025_bib9","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1016\/j.vaccine.2013.10.060","article-title":"Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program","volume":"31","author":"Ozaki","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2015.12.025_bib10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"304","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2015.12.025_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1542\/peds.78.4.736","article-title":"Clinical overview of varicella vaccine: development and early studies","volume":"78","author":"Takahashi","year":"1986","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2015.12.025_bib12","first-page":"287","article-title":"Chickenpox\/varicella zoster and vaccine in Japan","volume":"34","year":"2013","journal-title":"Infectious Agents Surveillance Report"},{"key":"10.1016\/j.bbmt.2015.12.025_bib13","first-page":"1926","article-title":"Vaccination after stem cell transplantation","volume":"54","author":"Kato","year":"2013","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.bbmt.2015.12.025_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2","article-title":"Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity","volume":"61","author":"Gomi","year":"2000","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.bbmt.2015.12.025_bib16","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2015.12.025_bib17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bmt.2010.31","article-title":"Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs","volume":"45","author":"Kussmaul","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bbmt.2011.05.006","article-title":"Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT)","volume":"17","author":"Chou","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajh.22196","article-title":"Experience with use of Zostavax((R)) in patients with hematologic malignancy and hematopoietic cell transplant recipients","volume":"87","author":"Naidus","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2015.12.025_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.coi.2012.06.002","article-title":"Immune senescence and vaccines to prevent herpes zoster in older persons","volume":"24","author":"Levin","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bbmt.2015.12.025_bib22","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bbmt.2015.12.025_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/sj.bmt.1704476","article-title":"Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants","volume":"33","author":"Spoulou","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.12.025_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","article-title":"Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation","volume":"156","author":"Inaba","year":"2012","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115019205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115019205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:19Z","timestamp":1761058519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115019205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1083879115019205"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.025","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}